ALXO Stock Analysis: Buy, Sell, or Hold?
ALXO - ALX Oncology Holdings Inc. Common Stock
$2.22
0.15 (7.00%)
▲
5d:
+8.58%
30d:
+32.63%
90d:
+12.44%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When ALXO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ALXO is 14.8% above its trading range ($1.93). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ALXO is 14.8% above its trading range ($1.93). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: ALXO is currently trading at $2.21, which is considered extended relative to its 30-day fair value range of $1.51 to $1.93.
Technical Outlook: Technically, ALXO is in a strong uptrend. The price is approaching resistance at $2.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.0% recently.
Market Sentiment: ALXO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.60 (+122.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ALXO is in a strong uptrend. The price is approaching resistance at $2.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.0% recently.
Market Sentiment: ALXO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.60 (+122.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.51 -
$1.93
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding ALXO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+14.8% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.0%)
- BULLISH: Trading 122.2% below Wall St target ($4.60)
Trading Range Analysis
30-Day Trading Range
$1.51 -
$1.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.41
Resistance Level
$2.26
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.85
Wall Street Target
$4.60
(+122.2%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 06, 2026 10:54 AM ET
Data refreshes hourly during market hours. Next update: 11:54 AM
Data refreshes hourly during market hours. Next update: 11:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALXO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Jason Lettmann
SELL
12311 shares
2026-03-19
Shelly Pinto
SELL
903 shares
2026-03-19
Corey S Goodman
BUY
3184713 shares
2026-02-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$435 | 64 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 62 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 61 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 58 HOLD |
Advanced ALXO Option Strategies
Professional options setups generated by AI based on today's ALXO price and gamma walls.
